ALPL Regulates Pro-angiogenic Capacity of Mesenchymal Stem Cells Through ATP-P2X7 Axis Controlled Exosomes Secretion

Overview

Journal J Nanobiotechnology

Publisher Biomed Central

Specialty Biotechnology

Date 2024 Apr 12

PMID 38609899

Authors

Jiayi Dong

Wanmin Zhao

Jiangdong Zhao

Ji Chen

Ping Liu

Xueni Zheng

Dehua Li

Yang Xue

Hongzhi Zhou

Affiliations

Soon will be listed here.

Abstract

Background: Early-onset bone dysplasia is a common manifestation of hypophosphatasia (HPP), an autosomal inherited disease caused by ALPL mutation. ALPL ablation induces prototypical premature bone ageing characteristics, resulting in impaired osteogenic differentiation capacity of human bone marrow mesenchymal stem cells (hBMMSCs). As angiogenesis is tightly coupled with osteogenesis, it also plays a necessary role in sustaining bone homeostasis. We have previously observed a decrease in expression of angiogenesis marker gene CD31 in the metaphysis of long bone in Alpl mice. However, the role of ALPL in regulation of angiogenesis in bone has remained largely unknown.

Methods: Exosomes derived from Normal and HPP hBMMSCs were isolated and identified by ultracentrifugation, transmission electron microscopy, and nanoparticle size measurement. The effects of ALPL on the angiogenic capacity of hBMMSCs from HPP patients were assessed by immunofluorescence, tube formation, wound healing and migration assay. exo-ELISA and Western Blot were used to evaluate the exosomes secretion of hBMMSCs from HPP, and the protein expression of VEGF, PDGFBB, Angiostatin and Endostatin in exosomes respectively.

Results: We verified that ALPL ablation resulted in impaired pro-angiogenic capacity of hBMMSCs, accounting for reduced migration and tube formation of human umbilical vein endothelial cells, as the quantities and proteins composition of exosomes varied with ALPL expression. Mechanistically, loss of function of ALPL enhanced ATP release. Additional ATP, in turn, led to markedly elevated level of ATP receptor P2X7, which consequently promoted exosomes secretion, resulting in a decreased capacity to promote angiogenesis. Conversely, inhibition of P2X7 increased the angiogenic induction capacity by preventing excessive release of anti-angiogenic exosomes in ALPL deficient-hBMMSCs.

Conclusion: The ALPL-ATP axis regulates the pro-angiogenic ability of hBMMSCs by controlling exosomes secretion through the P2X7 receptor. Thus, P2X7 may be proved as an effective therapeutic target for accelerating neovascularization in ALPL-deficient bone defects.

Citing Articles

Genomic analysis reveals population structure and selection signatures in plateau dairy cattle.

Huang S, Ma L, Li B, Dou J, Xu Q, Wang Y BMC Genomics. 2025; 26(1):240.

PMID: 40075267 PMC: 11905691. DOI: 10.1186/s12864-025-11335-0.

References

Rautiainen S, Laaksonen T, Koivuniemi R . Angiogenic Effects and Crosstalk of Adipose-Derived Mesenchymal Stem/Stromal Cells and Their Extracellular Vesicles with Endothelial Cells. Int J Mol Sci. 2021; 22(19). PMC: 8509224. DOI: 10.3390/ijms221910890. View

Yang X, Zhou F, Yuan P, Dou G, Liu X, Liu S . T cell-depleting nanoparticles ameliorate bone loss by reducing activated T cells and regulating the Treg/Th17 balance. Bioact Mater. 2021; 6(10):3150-3163. PMC: 7970013. DOI: 10.1016/j.bioactmat.2021.02.034. View

Carluccio M, Zuccarini M, Ziberi S, Giuliani P, Morabito C, Mariggio M . Involvement of P2X7 Receptors in the Osteogenic Differentiation of Mesenchymal Stromal/Stem Cells Derived from Human Subcutaneous Adipose Tissue. Stem Cell Rev Rep. 2019; 15(4):574-589. DOI: 10.1007/s12015-019-09883-6. View

Infante A, Rodriguez C . Osteogenesis and aging: lessons from mesenchymal stem cells. Stem Cell Res Ther. 2018; 9(1):244. PMC: 6158877. DOI: 10.1186/s13287-018-0995-x. View

Chen L, Zhang R, Xie J, Yang J, Fang K, Hong C . STAT3 activation by catalpol promotes osteogenesis-angiogenesis coupling, thus accelerating osteoporotic bone repair. Stem Cell Res Ther. 2021; 12(1):108. PMC: 7863540. DOI: 10.1186/s13287-021-02178-z. View

Li X, Wang X, Zhang C, Wang J, Wang S, Hu L . Dysfunction of metabolic activity of bone marrow mesenchymal stem cells in aged mice. Cell Prolif. 2022; 55(3):e13191. PMC: 8891618. DOI: 10.1111/cpr.13191. View

Bao L, Dou G, Tian R, Lv Y, Ding F, Liu S . Engineered neutrophil apoptotic bodies ameliorate myocardial infarction by promoting macrophage efferocytosis and inflammation resolution. Bioact Mater. 2021; 9:183-197. PMC: 8586716. DOI: 10.1016/j.bioactmat.2021.08.008. View

Bartlett R, Stokes L, Sluyter R . The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease. Pharmacol Rev. 2014; 66(3):638-75. DOI: 10.1124/pr.113.008003. View

Coppi E, Pugliese A, Urbani S, Melani A, Cerbai E, Mazzanti B . ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells. Stem Cells. 2007; 25(7):1840-9. DOI: 10.1634/stemcells.2006-0669. View

10.

Li L, Lu H, Zhao Y, Luo J, Yang L, Liu W . Functionalized cell-free scaffolds for bone defect repair inspired by self-healing of bone fractures: A review and new perspectives. Mater Sci Eng C Mater Biol Appl. 2019; 98:1241-1251. DOI: 10.1016/j.msec.2019.01.075. View

11.

Yang R, Yu T, Kou X, Gao X, Chen C, Liu D . Tet1 and Tet2 maintain mesenchymal stem cell homeostasis via demethylation of the P2rX7 promoter. Nat Commun. 2018; 9(1):2143. PMC: 5984622. DOI: 10.1038/s41467-018-04464-6. View

12.

Carotti V, Rigalli J, Van Asbeck-Van der Wijst J, Hoenderop J . Interplay between purinergic signalling and extracellular vesicles in health and disease. Biochem Pharmacol. 2022; 203:115192. DOI: 10.1016/j.bcp.2022.115192. View

13.

Hu H, Zhang H, Bu Z, Liu Z, Lv F, Pan M . Small Extracellular Vesicles Released from Bioglass/Hydrogel Scaffold Promote Vascularized Bone Regeneration by Transferring miR-23a-3p. Int J Nanomedicine. 2022; 17:6201-6220. PMC: 9749034. DOI: 10.2147/IJN.S389471. View

14.

Peng Y, Wu S, Li Y, Crane J . Type H blood vessels in bone modeling and remodeling. Theranostics. 2020; 10(1):426-436. PMC: 6929606. DOI: 10.7150/thno.34126. View

15.

Liu W, Li L, Rong Y, Qian D, Chen J, Zhou Z . Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126. Acta Biomater. 2019; 103:196-212. DOI: 10.1016/j.actbio.2019.12.020. View

16.

Wulff K, Gatti S, Wettstein J, Foster R . Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat Rev Neurosci. 2010; 11(8):589-99. DOI: 10.1038/nrn2868. View

17.

Lopatina T, Bruno S, Tetta C, Kalinina N, Porta M, Camussi G . Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential. Cell Commun Signal. 2014; 12:26. PMC: 4022079. DOI: 10.1186/1478-811X-12-26. View

18.

Robbins P, Morelli A . Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 2014; 14(3):195-208. PMC: 4350779. DOI: 10.1038/nri3622. View

19.

Wang K, Li Y, Ren C, Wang Y, He W, Jiang Y . Extracellular Vesicles as Innovative Treatment Strategy for Amyotrophic Lateral Sclerosis. Front Cell Dev Biol. 2021; 9:754630. PMC: 8632491. DOI: 10.3389/fcell.2021.754630. View

20.

Lin Y, Nan J, Shen J, Lv X, Chen X, Lu X . Canagliflozin impairs blood reperfusion of ischaemic lower limb partially by inhibiting the retention and paracrine function of bone marrow derived mesenchymal stem cells. EBioMedicine. 2020; 52:102637. PMC: 6992997. DOI: 10.1016/j.ebiom.2020.102637. View